Tag Archives: Avenue Capital Group

Epica Secures $18MM Growth Capital Credit Facility from Avenue Capital

Epica International, a global company in advanced medical imaging and precision robotics, closed an $18 million growth capital credit facility with Avenue Venture Opportunities Fund and Avenue Venture Opportunities Fund II, which are funds of Avenue Capital.

CytoSorbents Secures $20MM Credit Facility from Avenue Capital Group

CytoSorbents entered into a new $20 million credit facility with Avenue Capital Group, including its Avenue Venture Opportunities Fund and Avenue Venture Opportunities Fund II, on June 28, 2024. Armentum Partners served as financial advisor to the company on the transaction.